Trial intelligence / Profile preview

Kuntai capsule versus DHEA for diminished ovarian reserve

ChiCTR-TRC-13004085Phase 4Completed

Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Start
Jan 2014
Countries
1
01

Overview

Phase 4, open-label trial of Kuntai in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Hormonal profile, Bilateral ovarian antral follicle count and 8 more. Started Jan 2014; status: completed.

02

Drugs

Kuntai
03

Conditions

Diminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on ChiCTR-TRC-13004085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13004085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call